We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

90 hedge funds and large institutions have $276M invested in Cardiovascular Systems, Inc. in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $808K | Put options by funds: $365K

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

2% more funds holding

Funds holding: 8890 (+2)

4% less capital invested

Capital invested by funds: $286M → $276M (-$10.2M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
90
Holders Change
+2
Holders Change %
+2.27%
% of All Funds
2.92%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
11
Increased
39
Reduced
24
Closed
8
Calls
$808K
Puts
$365K
Net Calls
+$443K
Net Calls Change
+$443K
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$1.95M +$140K +6,709 +7%
TCIM
27
TIAA CREF Investment Management
New York
$1.93M -$101K -4,861 -5%
TCM
28
Timpani Capital Management
Wisconsin
$1.83M -$1.08M -51,711 -36%
Ameriprise
29
Ameriprise
Minnesota
$1.8M +$328K +15,771 +21%
TA
30
Teton Advisors
New York
$1.79M +$119K +5,700 +7%
WA
31
WFG Advisors
Texas
$1.66M -$342K -16,450 -17%
RFC
32
Russell Frank Company
Washington
$1.34M -$326K -15,681 -19%
Morgan Stanley
33
Morgan Stanley
New York
$1.32M -$315K -15,122 -19%
CC
34
Curian Capital
Colorado
$1.27M +$23.7K +1,137 +2%
SCM
35
Sterling Capital Management
North Carolina
$1.21M
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$1.19M -$889K -42,718 -42%
BIM
37
BlackRock Investment Management
Delaware
$1.19M +$79.3K +3,812 +7%
Cambridge Investment Research Advisors
38
Cambridge Investment Research Advisors
Iowa
$1.05M +$20.8K +1,000 +2%
CCI
39
Columbus Circle Investors
$967K +$596K +28,618 +146%
Bank of America
40
Bank of America
North Carolina
$931K -$144K -6,920 -13%
AQR Capital Management
41
AQR Capital Management
Connecticut
$909K +$536K +25,731 +131%
Charles Schwab
42
Charles Schwab
California
$857K +$46.4K +2,231 +6%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$755K +$24.9K +1,195 +3%
WFM
44
Wilmington Funds Management
Delaware
$751K
AllianceBernstein
45
AllianceBernstein
Tennessee
$688K +$99.9K +4,800 +16%
Deutsche Bank
46
Deutsche Bank
Germany
$644K +$296K +14,205 +79%
TA
47
Teachers Advisors
New York
$579K +$23.9K +1,149 +4%
CS
48
Credit Suisse
Switzerland
$576K +$98.1K +4,711 +20%
KeyBank National Association
49
KeyBank National Association
Ohio
$504K +$40.2K +1,932 +8%
NCCM
50
Nine Chapters Capital Management
New Jersey
$489K +$508K +24,400 New

CSII Hedge Fund Activity: Q3 2013 in Review

90 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2013, worth a combined $276M — down 3.6% from $286M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CSII positions and 8 closed out — a net gain of 3 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $5.32M. The largest seller was Castleark Management, exiting entirely with an estimated $3.35M sold.

  • 90 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2013, up from 88 in Q2 2013.
  • Funds reported $276M of Cardiovascular Systems, Inc. stock for Q3 2013, down 3.6% quarter-over-quarter.
  • 11 funds opened new Cardiovascular Systems, Inc. positions in Q3 2013 and 8 closed out, a net change of +3 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2013 was Consonance Capital Management, an estimated $5.32M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2013 was Castleark Management, an estimated $3.35M sold.

Based on aggregated 13F filings for Q3 2013.